Cresco Labs (CRLBF) Cash & Equivalents (2019 - 2026)
Cresco Labs' (CRLBF) quarterly Cash & Equivalents came in at $32.3 million in Q1 2026, down 44.14% on a QoQ basis from $57.9 million in Q4 2025.
Cresco Labs (CRLBF) Cash & Equivalents (2019 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 8 years of Cash & Equivalents data on file, last reported at $32.3 million in Q1 2026.
- Quarterly Cash & Equivalents changed N/A year-over-year to $32.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.3 million (changed N/A YoY) and the FY2025 annual result came in at $57.9 million, changed N/A from the prior year.
- Cash & Equivalents fell to $32.3 million in Q1 2026, from $57.9 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $226.1 million in Q1 2022 to a low of $32.3 million in Q1 2026.
- A 5-year average of $106.4 million and a median of $103.4 million in 2023 frame the typical range for Cash & Equivalents.
- The widest YoY moves for Cash & Equivalents: up 12.69% in 2022, down 12.69% in 2022.
- Tracing CRLBF's Cash & Equivalents over 5 years: stood at $226.1 million in 2022, then sank by 54.26% to $103.4 million in 2023, then grew by 8.57% to $112.3 million in 2024, then sank by 48.44% to $57.9 million in 2025, then tumbled by 44.14% to $32.3 million in 2026.
- The last three Cash & Equivalents figures came in at $32.3 million (Q1 2026), $57.9 million (Q4 2025), and $112.3 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 164.00 Mn |
| 10 | Cresco Labs | 292.94 Mn | 228.83 Mn | 86.95 Mn | 32.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.35 Mn |
| Dec 31, 2025 | 57.90 Mn |
| Jun 30, 2024 | 112.30 Mn |
| Dec 31, 2023 | 103.43 Mn |
| Mar 31, 2022 | 226.10 Mn |
| Dec 31, 2021 | 2.56 Mn |
| Sep 30, 2021 | 140.77 Mn |
| Jun 30, 2021 | 135.23 Mn |
| Mar 31, 2021 | 258.97 Mn |
| Dec 31, 2020 | 25.30 Mn |
| Sep 30, 2020 | 59.62 Mn |
| Mar 31, 2020 | 70.03 Mn |
| Dec 31, 2019 | 5.05 Mn |